The use of caspofungin for fungal infections

被引：0
|
作者：
Bouza, E [1 ]
Muñoz, P [1 ]
机构：
[1] Univ Madrid, Hosp Gen Gregorio Maranon, Serv Microbiol Clin & Enfermedades Infecciosas, E-28007 Madrid, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2002年
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：38 / 42
页数：5
相关论文
共 50 条
  • [31] Development and Evaluation of 99mTc-Tricarbonyl-Caspofungin as Potential Diagnostic Agent of Fungal Infections
    Reyes, Ana L.
    Fernandez, Leticia
    Rey, Ana
    Teran, Mariclla
    CURRENT RADIOPHARMACEUTICALS, 2014, 7 (02) : 144 - 150
  • [32] Voriconazole Use for Endemic Fungal Infections
    Freifeld, Alison
    Proia, Laurie
    Andes, David
    Baddour, Larry M.
    Blair, Janis
    Spellberg, Brad
    Arnold, Sandra
    Lentnek, Arnold
    Wheat, L. Joseph
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1648 - 1651
  • [33] COST COMPARISON OF LIPOSOMAL AMPHOTERICIN B VS CASPOFUNGIN FOR THE EMPIRICAL TREATMENT OF INVASIVE FUNGAL INFECTIONS
    Malyszczak, W.
    Jones, B. L.
    Jackson, B.
    Malyszczak, W.
    Agrawal, S.
    Jensen, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 321 - 321
  • [34] Economic evaluation of caspofungin versus liposomal amphotericin B in the empiric treatment of fungal infections in Italy
    Stam, W.
    Aversa, F.
    Kumar, R.
    Jansen, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S231 - S231
  • [35] Caspofungin after solid organ transplantation in Germany. Observational study on treatment of invasive fungal infections
    Lichtenstern, C.
    Pratschke, J.
    Schulz, U.
    Schmoeckel, M.
    Knitsch, W.
    Kaskel, P.
    Krobot, K. J.
    Weigand, M. A.
    Winkler, M.
    ANAESTHESIST, 2010, 59 (12): : 1083 - 1090
  • [36] Caspofungin for prophylaxis and treatment of fungal infections in adolescents and adults: a meta-analysis of randomized controlled trials
    Yuan, Xin
    Wang, Rui
    Bai, Chang-qing
    Song, Xiu-jie
    Liu, You-ning
    PHARMAZIE, 2012, 67 (04): : 267 - 273
  • [37] Pharmacoeconomic evaluation of caspofungin versus liposomal amphotericin B in empirical treatment of invasive fungal infections in Turkey
    Turner, S. J.
    Senol, E.
    Kara, A.
    Al-Badriyeh, D.
    Kong, D. C. M.
    Dinleyici, E. C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (03) : 276 - 280
  • [38] Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies
    Candoni, A
    Mestroni, R
    Damiani, D
    Tiribelli, M
    Michelutti, A
    Silvestri, F
    Castelli, M
    Viale, P
    Fanin, R
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (03) : 227 - 233
  • [39] Factors influencing caspofungin plasma concentrations in kidney transplant patients with high incidence of invasive fungal infections
    Yang, Qianting
    Zhang, Tao
    Zhao, Dan
    Zhang, Ying
    Dong, Yuzhu
    Sun, Dan
    Du, Qian
    Zheng, Jing
    Lu, Haidong
    Dong, Yalin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (01) : 72 - 80
  • [40] Breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin
    Morris, Shaun K.
    Allen, Upton D.
    Gupta, Sumit
    Richardson, Susan E.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2012, 23 (04): : 179 - 182
12345